BCLS ACQUISITION CORP's ticker is BLSA and the CUSIP is G0904B105. A total of 53 filers reported holding BCLS ACQUISITION CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $200,000 | +0.5% | 20,000 | 0.0% | 0.02% | +7.1% |
| Q2 2022 | $199,000 | +0.5% | 20,000 | 0.0% | 0.01% | +27.3% |
| Q1 2022 | $198,000 | +1.0% | 20,000 | 0.0% | 0.01% | +57.1% |
| Q4 2021 | $196,000 | -1.5% | 20,000 | 0.0% | 0.01% | -12.5% |
| Q3 2021 | $199,000 | -5.7% | 20,000 | 0.0% | 0.01% | +14.3% |
| Q2 2021 | $211,000 | 0.0% | 20,000 | 0.0% | 0.01% | -36.4% |
| Q1 2021 | $211,000 | -5.4% | 20,000 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $223,000 | – | 20,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 843,122 | $8,263,000 | 3.47% |
| Finepoint Capital LP | 603,429 | $5,950,000 | 1.52% |
| Samsara BioCapital, LLC | 300,000 | $2,940,000 | 0.57% |
| COMMODORE CAPITAL LP | 250,000 | $2,450,000 | 0.57% |
| Bain Capital Life Sciences Investors, LLC | 487,500 | $4,778,000 | 0.38% |
| Asymmetry Capital Management, L.P. | 71,372 | $699,000 | 0.37% |
| First Trust Capital Management L.P. | 206,257 | $2,021,000 | 0.35% |
| Exos Asset Management LLC | 68,672 | $673,000 | 0.35% |
| Altium Capital Management LP | 100,000 | $980,000 | 0.27% |
| SPHERA FUNDS MANAGEMENT LTD. | 216,250 | $2,132,000 | 0.23% |